StonvexLoading…
StonvexStonvexStonvexCore line items from PHIN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $878.00M | $3.48B | $2.59B | $1.69B |
Operating Income | $69.00M | $254.00M | $185.00M | $151.00M |
Net Income | $37.00M | $130.00M | $85.00M | $72.00M |
EPS (Diluted) | $0.96 | $3.24 | $2.10 | $1.76 |
Total Assets | $3.80B | $3.82B | $3.99B | $3.89B |
Total Liabilities | $2.25B | $2.23B | $2.40B | $2.27B |
Cash & Equivalents | $328.00M | $359.00M | $349.00M | $347.00M |
Free Cash Flow OCF − CapEx | $21.00M | $188.00M | $121.00M | $28.00M |
Shares Outstanding | 38.70M | 37.92M | 40.40M | 40.80M |